Administration and Safety TB-500 Administration: Commonly given via subcutaneous injection Typically used in 46 week cycles Initial phase: 23 injections per week Maintenance phase: Reduced frequency as directed by a healthcare provider BPC-157 Administration: Can be taken via subcutaneous injection, localized injection, or oral capsule (for gut health) Dosage varies depending on injury type and severity Can be used for short-term injury recovery or longer cycles for chronic conditions Safety Note: Both TB-500 and BPC-157 should be used under medical supervision
This 10ml vial suits researchers preparing larger volumes or multiple reconstitutions, while the 3ml vial suits smaller, single-use research setups
However, no killing was observed upon supplementation with exogenous glutathione (G)
(2021) Tag-free internal RNA labeling and photocaging based on mRNA methyltransferases, Angewandte Chemie , 60 , 4098-4103, Michailidou, F., Klcker, N., Cornelissen, N